A Cognitive Behavioral Therapy-Based Text Messaging Intervention for Methamphetamine Dependence
NCT01577797 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2013-07-10
Summary
This Phase I, randomized, 22-day crossover study seeks to improve treatment outcomes for methamphetamine-dependent subjects by developing a cognitive behavioral therapy (CBT)- based short message service (SMS) text messaging intervention as an adjunct to CBT group therapy.
Conditions
- Methamphetamine Dependence
Interventions
- BEHAVIORAL
-
Text messages
Messages sent at random intervals 4 times per day during weeks 1 and 3. Subjects can also request messages if they are craving methamphetamine
Sponsors & Collaborators
-
New Leaf Treatment Center
lead OTHER
Principal Investigators
-
S. Alex Stalcup, MD · New Leaf Treatment Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-04-30
- Primary Completion
- 2013-07-31
- Completion
- 2013-07-31
Countries
- United States
Study Locations
More Related Trials
-
Methylphenidate to Treat Methamphetamine Dependence
NCT01044238 ·Status: UNKNOWN ·Phase: PHASE2
-
Exercise in Methamphetamine Use Disorder Upregulation and Neural Function
NCT03709667 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Topiramate for the Treatment of Methamphetamine Dependence - 1
NCT00345371 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Trial of Dextroamphetamine for Methamphetamine Dependence
NCT00630682 ·Status: COMPLETED ·Phase: PHASE2
-
Digital Therapeutics Smartphone Application for Methamphetamine Use Disorder
NCT05550493 ·Status: COMPLETED ·Phase: NA
-
Transcranial Direct Current Stimulation (tDCS) Combined With Computerized Cognitive Addiction Therapy(CCAT) and, Electronic Follow-up for Methamphetamine(MA) Dependent Patients
NCT04139148 ·Status: UNKNOWN ·Phase: NA
-
Individualized Neuromodulation of Craving Control for Meth Use Disorders
NCT06695637 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Varenicline vs Placebo for the Treatment of Methamphetamine Dependence
NCT01011829 ·Status: COMPLETED ·Phase: PHASE2
-
Field Study of a Digital Therapeutic Platform to Facilitate Treatment for Methamphetamine-Primary Stimulant Use Disorder
NCT05266716 ·Status: COMPLETED ·Phase: NA
-
A Randomized, Placebo-Controlled Trial of Modafinil for Methamphetamine Dependence
NCT01354470 ·Status: COMPLETED ·Phase: PHASE2
-
Varenicline as a Treatment for Methamphetamine Dependence
NCT01571167 ·Status: COMPLETED ·Phase: PHASE1
-
Citicoline Treatment of Methamphetamine Dependence
NCT00950352 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial of Acamprosate for Treatment of Methamphetamine Addiction
NCT00571922 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse
NCT00809835 ·Status: COMPLETED ·Phase: PHASE2
-
Prometa Pharmacotherapy for Methamphetamine Dependence
NCT00260481 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Studying Amphetamine Withdrawal in Humans
NCT01215929 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Interaction Trial Ibudilast and Methamphetamine
NCT01217970 ·Status: COMPLETED ·Phase: PHASE1
-
Bupropion for the Treatment of Methamphetamine Dependence - 1
NCT00069251 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Pomaglumetad and Methamphetamine
NCT03106571 ·Status: TERMINATED ·Phase: PHASE1
-
A Study for the Risky Decision-making Deficits Among Methamphetamine Dependence Individuals and Treatment
NCT06279273 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Ondansetron for the Treatment of Methamphetamine Dependence - 1
NCT00040053 ·Status: COMPLETED ·Phase: PHASE2
-
An Assessment of the Safety of Varenicline in Methamphetamine-dependent Volunteers
NCT00713479 ·Status: COMPLETED ·Phase: PHASE1
-
Targeting Drug Memories With Methylphenidate
NCT05978167 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Smartphone Services for Stimulant Use Disorder
NCT07092059 ·Status: RECRUITING ·Phase: NA
-
Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence
NCT00687713 ·Status: COMPLETED ·Phase: PHASE2